SCOPUS 정보 검색 플랫폼

Volumn 69, Issue 10, 2007, Pages 1063-1065

Fluctuations of CSF amyloid-β levels: Implications for a diagnostic and therapeutic biomarker [5]

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL;

EID: 34548401594 PISSN: 00283878 EISSN: None Source Type: Journal
DOI: 10.1212/01.wnl.0000284702.01399.56 Document Type: Letter

Times cited : (4)

References (8)

1
- 33947507128
- Fluctuations of CSF amyloid-β levels: implications for a diagnostic and therapeutic biomarker
- RJ Bateman G Wen JC Morris DM Holtzman Fluctuations of CSF amyloid-β levels: implications for a diagnostic and therapeutic biomarker Neurology 68 2007 666 669
- (2007) Neurology , vol.68 , pp. 666-669
- Bateman, RJ¹ Wen, G² Morris, JC³ Holtzman, DM⁴

2
- 0033061647
- Cerebrospinal fluid beta-amyloid(1–42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease
- N Andreasen C Hesse P Davidsson Cerebrospinal fluid beta-amyloid(1–42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch Neurol 56 1999 673 680
- (1999) Arch Neurol , vol.56 , pp. 673-680
- Andreasen, N¹ Hesse, C² Davidsson, P³

3
- 0026572465
- Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients
- WE Van Nostrand SL Wagner WR Shankle Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients Proc Natl Acad Sci USA 89 1992 2551 2555
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 2551-2555
- Van Nostrand, WE¹ Wagner, SL² Shankle, WR³

4
- 0344672942
- APP processing and synaptic function
- F Kamenetz T Tomita H Hsieh APP processing and synaptic function Neuron 37 2003 925 937
- (2003) Neuron , vol.37 , pp. 925-937
- Kamenetz, F¹ Tomita, T² Hsieh, H³

5
- 33947223454
- Cerebrospinal fluid tau/beta-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
- AM Fagan CM Roe C Xiong MA Mintun JC Morris DM Holtzman Cerebrospinal fluid tau/beta-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349
- (2007) Arch Neurol , vol.64 , pp. 343-349
- Fagan, AM¹ Roe, CM² Xiong, C³ Mintun, MA⁴ Morris, JC⁵ Holtzman, DM⁶

6
- 0037514257
- Decreased b-amyloid1–42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease
- T Sunderland G Linker N Mirza Decreased b-amyloid1–42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease JAMA 289 2003 2094 2103
- (2003) JAMA , vol.289 , pp. 2094-2103
- Sunderland, T¹ Linker, G² Mirza, N³

7
- 32544435900
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
- O Hansson H Zetterberg P Buchhave E Londos K Blennow L Minthon Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol 5 2006 228 234
- (2006) Lancet Neurol , vol.5 , pp. 228-234
- Hansson, O¹ Zetterberg, H² Buchhave, P³ Londos, E⁴ Blennow, K⁵ Minthon, L⁶

8
- 33644832047
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A beta(42) in humans
- AM Fagan MA Mintun RH Mach Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A beta(42) in humans Ann Neurol 59 2006 512 519
- (2006) Ann Neurol , vol.59 , pp. 512-519
- Fagan, AM¹ Mintun, MA² Mach, RH³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.